Our previous investigations indicated the significant differences between serum levels of CXCL8 and/or CXCR2 in cancer patients and healthy individuals; however, these studies were performed on pancreatic [22,23], colorectal [24,25] as well as esophageal cancer [20,21] patients. This evidence concerns the gene CXCL8 and cancer.